Clinical trial

Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Participants

NCT02065700

Study summary

ClinicalTrials.gov

Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Participants

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Filgotinib Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-02-25

PhasePHASE2

Conditions

Rheumatoid Arthritisverified · MONDO: rheumatoid arthritis

Interventions

FilgotinibDRUG

Sponsors & collaborators

Lakefront Biotherapeutics NVlead sponsor

Gilead Sciencescollaborator

Mapped research locations

Buenos AiresArgentina3 KrakowPoland3 SofiaBulgaria3 KharkivUkraine3 SantiagoChile3 BogotáColombia3 MoscowRussia2 WarsawPoland2 BudapestHungary2 HaifaIsrael2 A CoruñaSpain2 HoustonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02065700 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.